Literature DB >> 21640624

Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy.

Gerasimos Terzis1, Filippos Dimopoulos, George K Papadimas, Constantinos Papadopoulos, Konstantinos Spengos, Ioannis Fatouros, Stavros A Kavouras, Panagiota Manta.   

Abstract

Pompe disease is a rare autosomal recessive disorder characterized by the deficiency of acid α-glycosidase resulting in lysosomal accumulation of glycogen. The late-onset disease form is characterized by progressive skeletal and respiratory muscle dysfunction. In addition to the recently introduced enzyme replacement therapy (ERT), treatments such as protein-enriched diet and exercise training have been proposed, although little is known about their effectiveness on the physical condition of such patients. Aim of the present study was to investigate the effect of exercise training on muscular strength and body composition in five patients with late-onset Pompe disease receiving ERT. All subjects followed a 20 week lasting program of supervised aerobic and progressive resistance exercise training. Before and after the training period, body composition was determined with dual X-ray absorptiometry and isometric muscular strength was measured with a specialized load transducer. Functional capacity was assessed using the 6-min shuttle walk test. A significant increase in muscular strength (15-50% at various body parts, p<0.05) and 6-minute walking distance (203.8 ± 177 m before vs. 248.2 ± 184 m after, p<0.01) was observed after training, whereas total and lower extremities lean body mass did not change significantly. These results suggest that exercise training has a positive effect on muscular strength and functional capacity in patients on ERT with late-onset Pompe disease. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21640624     DOI: 10.1016/j.ymgme.2011.05.013

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  16 in total

Review 1.  Enzyme replacement therapy for Pompe disease.

Authors:  Corrado Angelini; Claudio Semplicini
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 2.  Nutrition and exercise in Pompe disease.

Authors:  Mark A Tarnopolsky; Mats I Nilsson
Journal:  Ann Transl Med       Date:  2019-07

3.  Respiratory muscle training in late-onset Pompe disease: Results of a sham-controlled clinical trial.

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson-Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Neuromuscul Disord       Date:  2020-09-28       Impact factor: 4.296

Review 4.  Treatment Opportunities in Patients With Metabolic Myopathies.

Authors:  Mette Cathrine Ørngreen; John Vissing
Journal:  Curr Treat Options Neurol       Date:  2017-09-21       Impact factor: 3.598

5. 

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2019-05-08       Impact factor: 4.797

Review 6.  Exercise in muscle glycogen storage diseases.

Authors:  Nicolai Preisler; Ronald G Haller; John Vissing
Journal:  J Inherit Metab Dis       Date:  2014-10-18       Impact factor: 4.982

Review 7.  Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review.

Authors:  Antonio Toscano; Benedikt Schoser
Journal:  J Neurol       Date:  2012-08-28       Impact factor: 4.849

Review 8.  Glycogen metabolism in humans.

Authors:  María M Adeva-Andany; Manuel González-Lucán; Cristóbal Donapetry-García; Carlos Fernández-Fernández; Eva Ameneiros-Rodríguez
Journal:  BBA Clin       Date:  2016-02-27

9.  Lack of robust satellite cell activation and muscle regeneration during the progression of Pompe disease.

Authors:  Gerben J Schaaf; Tom J M van Gestel; Esther Brusse; Robert M Verdijk; Irenaeus F M de Coo; Pieter A van Doorn; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Acta Neuropathol Commun       Date:  2015-10-28       Impact factor: 7.801

10.  Exercise testing in late-onset glycogen storage disease type II patients undergoing enzyme replacement therapy.

Authors:  Mauro Marzorati; Simone Porcelli; Giuseppe Bellistri; Lucia Morandi; Bruno Grassi
Journal:  Neuromuscul Disord       Date:  2012-12       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.